Tiagabine Hydrochloride
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 6 | SUPPLYING |
| Teva Pharmaceuticals USA, Inc. | generic | 4 | EXITED 2026 |
Shortages, recalls, and registration changes attached to this drug concept.
Tiagabine Hydrochloride Tablet — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Neurology.
Tiagabine Hydrochloride Tablet — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Neurology.
Failed Impurities: Out of Specification (OOS) result observed during Related Substances testing — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Distributed nationwide in the USA.
